Slawek J - Search Results

1

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Csikós J, Cairney CJ, Blitzer A. Jost WH, et al. Among authors: slawek j. Neurology. 2019 Apr 23;92(17):e1982-e1991. doi: 10.1212/WNL.0000000000007368. Epub 2019 Mar 27. Neurology. 2019. PMID: 30918101 Free PMC article. Clinical Trial.

2

[Dopa-responsive dystonia (Segawa variant): clinical analysis of 7 cases with delayed diagnosis].

Sławek J, Friedman A, Bogucki A, Budrewicz S, Banach M. Sławek J, et al. Neurol Neurochir Pol. 2003;37 Suppl 5:117-26. Neurol Neurochir Pol. 2003. PMID: 15098338 Polish.

3

Quality of life in Polish patients with long-lasting Parkinson's disease.

Zach M, Friedman A, Sławek J, Derejko M. Zach M, et al. Among authors: slawek j. Mov Disord. 2004 Jun;19(6):667-72. doi: 10.1002/mds.10698. Mov Disord. 2004. PMID: 15197705

4

[Botulinum toxin type A in the management of spasticity in adults: recommendations of an interdisciplinary group of experts].

Sławek J, Bogucki A, Banach M, Członkowska A, Friedman A, Krawczyk M, Kwolek A, Opara J, Ochudło S, Zaborski J. Sławek J, et al. Neurol Neurochir Pol. 2004 Nov-Dec;38(6):443-5. Neurol Neurochir Pol. 2004. PMID: 15654667 Polish. No abstract available.

5

Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.

Slawek J, Bogucki A, Reclawowicz D. Slawek J, et al. Neurol Sci. 2005 Apr;26(1):32-9. doi: 10.1007/s10072-005-0379-8. Neurol Sci. 2005. PMID: 15877185 Clinical Trial.

6

Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.

Slawek J, Friedman A, Potulska A, Krystkowiak P, Gervais C, Banach M, Ochudlo S, Budrewicz S, Reclawowicz D, Rynkowski M, Opala G. Slawek J, et al. Funct Neurol. 2007 Apr-Jun;22(2):95-100. Funct Neurol. 2007. PMID: 17637212

7

Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease.

Koziorowski D, Hoffman-Zacharska D, Sławek J, Szirkowiec W, Janik P, Bal J, Friedman A. Koziorowski D, et al. Among authors: slawek j. Parkinsonism Relat Disord. 2010 Feb;16(2):136-8. doi: 10.1016/j.parkreldis.2009.06.010. Epub 2009 Jul 22. Parkinsonism Relat Disord. 2010. PMID: 19628420

8

[Continuous dopaminergic stimulation - clinical experience].

Bogucki A, Sławek J. Bogucki A, et al. Among authors: slawek j. Neurol Neurochir Pol. 2010 Jul-Aug;44(4):385-95. doi: 10.1016/s0028-3843(14)60298-x. Neurol Neurochir Pol. 2010. PMID: 20827612 Review. Polish.

9

[Levodopa intestinal infusion therapy in Parkinson's disease].

Sławek J, Bogucki A. Sławek J, et al. Neurol Neurochir Pol. 2010 Jul-Aug;44(4):396-403. doi: 10.1016/s0028-3843(14)60299-1. Neurol Neurochir Pol. 2010. PMID: 20827613 Review. Polish.

10

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease.

Hauser RA, Slawek J, Barone P, Dohin E, Surmann E, Asgharnejad M, Bauer L. Hauser RA, et al. Among authors: slawek j. BMC Neurol. 2016 Jun 7;16:90. doi: 10.1186/s12883-016-0610-7. BMC Neurol. 2016. PMID: 27267880 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters